{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:45:09Z","timestamp":1790275509108,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T00:00:00Z","timestamp":1444953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1208\/s12249-015-0432-8","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T23:40:16Z","timestamp":1445211616000},"page":"988-994","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Studies on Aspirin Crystals Generated by a Modified Vapor Diffusion Method"],"prefix":"10.1208","volume":"17","author":[{"given":"Amit","family":"Mittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamilvanan","family":"Shunmugaperumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,16]]},"reference":[{"key":"432_CR1","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/jps.2600640805","volume":"64","author":"JK Haleblian","year":"1975","unstructured":"Haleblian JK. Characterization of habits and crystalline modification of solids and their pharmaceutical applications. J Pharm Sci. 1975;64:1269\u201388.","journal-title":"J Pharm Sci"},{"key":"432_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-5173(00)00551-2","volume":"208","author":"HA Garekani","year":"2000","unstructured":"Garekani HA, Ford HA, Rubinstein MH, Rajabi-Siahboomi AR. Highly compressible paracetamol-II. Compression properties. Int J Pharm. 2000;208:101\u201310.","journal-title":"Int J Pharm"},{"key":"432_CR3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1081\/DDC-100107327","volume":"27","author":"AK Tiwary","year":"2001","unstructured":"Tiwary AK. Modification of crystal habit and its role in dosage form performance. Drug Dev Ind Pharm. 2001;27:699\u2013709.","journal-title":"Drug Dev Ind Pharm"},{"key":"432_CR4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-5173(02)00296-X","volume":"244","author":"N Rasenack","year":"2002","unstructured":"Rasenack N, M\u00fcller BW. Crystal habit and tableting behavior. Int J Pharm. 2002;244:45\u201357.","journal-title":"Int J Pharm"},{"key":"432_CR5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(99)00157-X","volume":"187","author":"A Garekani","year":"1999","unstructured":"Garekani A, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. Formation and compression characteristics of prismatic polyhedral and thin plate-like crystals of paracetamol. Int J Pharm. 1999;187:77\u201389.","journal-title":"Int J Pharm"},{"key":"432_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcrysgro.2004.11.323","volume":"276","author":"YJ Liu","year":"2005","unstructured":"Liu YJ, Wang J, Yin Q. The crystal habit of ciprofloxacin hydrochloride monohydrate crystal. J Cryst Growth. 2005;276:237\u201342.","journal-title":"J Cryst Growth"},{"key":"432_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(00)00550-0","volume":"208","author":"A Garekani","year":"2000","unstructured":"Garekani A, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR. Highly compressible paracetamol: I: crystallization and characterization. Int J Pharm. 2000;208:87\u201399.","journal-title":"Int J Pharm"},{"key":"432_CR8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jcrysgro.2004.10.158","volume":"274","author":"A Nokhodchi","year":"2005","unstructured":"Nokhodchi A, Bolourtchian N, Dinarvand R. Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives. J Cryst Growth. 2005;274:573\u201384.","journal-title":"J Cryst Growth"},{"key":"432_CR9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/cg050242g","volume":"38","author":"M Mirmehrabi","year":"2006","unstructured":"Mirmehrabi M, Rohani S, Murthy KSK, Radatus P. Polymorphic behavior and crystal habit of an anti-viral\/HIV drug: stavudine. Cryst Growth Des. 2006;38:141\u20139.","journal-title":"Cryst Growth Des"},{"key":"432_CR10","doi-asserted-by":"crossref","DOI":"10.1002\/3527607889","volume-title":"Polymorphism: in the pharmaceutical industry","author":"R Hilfiker","year":"2006","unstructured":"Hilfiker R. Polymorphism: in the pharmaceutical industry. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2006."},{"key":"432_CR11","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1039\/c1ce05778b","volume":"13","author":"PP Bag","year":"2011","unstructured":"Bag PP, Patni M, Reddy CM. A kinetically controlled crystallization process for identifying new co-crystal forms: fast evaporation of solvent from solutions to dryness. Cryst Eng Comm. 2011;13:5650\u20132.","journal-title":"Cryst Eng Comm"},{"key":"432_CR12","first-page":"183","volume-title":"Polymorphism in pharmaceutical solids","author":"JK Guillory","year":"1999","unstructured":"Guillory JK. Generation of polymorphs, hydrates, solvates and amorphous solids. In: Brittain HG, editor. Polymorphism in pharmaceutical solids. New York: Marcel Dekker, Inc; 1999. p. 183\u2013226."},{"key":"432_CR13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3109\/03639045.2011.555407","volume":"37","author":"S Tamilvanan","year":"2011","unstructured":"Tamilvanan S, Kumar BA. Influence of acetazolamide loading on the (in vitro) performances of non-phospholipid-based cationic nanosized emulsion in comparison with phospholipid-based anionic and neutral-charged nanosized emulsions. Drug Dev Ind Pharm. 2011;37:1003\u201315.","journal-title":"Drug Dev Ind Pharm"},{"key":"432_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s13346-013-0187-2","volume":"4","author":"S Tamilvanan","year":"2014","unstructured":"Tamilvanan S, Vinaykumar DS, Ashutosh T. In vitro evaluation of polyethylene glycol-based microparticles containing azithromycin. Drug Del Translat Res. 2014;4:139\u201348.","journal-title":"Drug Del Translat Res"},{"key":"432_CR15","doi-asserted-by":"crossref","first-page":"16802","DOI":"10.1021\/ja056455b","volume":"127","author":"P Vishweshwar","year":"2005","unstructured":"Vishweshwar P, McMahon J, Oliveira M, Peterson ML, Zaworotko MJ. The predictably elusive form II of aspirin. J Am Chem Soc. 2005;127:16802\u20133.","journal-title":"J Am Chem Soc"},{"key":"432_CR16","unstructured":"Almarsson O, McMahon J, Vishweshwar P, Peterson M, Zaworotko MJ. Novel polymorph of acetylsalicylic acid, and methods of making and using the same. US Patent Publication Number: US2010\/0331285 A1, Publication Date: Dec 30 2010."},{"key":"432_CR17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/anie.200603373","volume":"46","author":"AD Bond","year":"2007","unstructured":"Bond AD, Boese R, Desiraju GR. On the polymorphism of aspirin: crystalline aspirin as intergrowths of two polymorphic domains. Angew Chem Int Ed. 2007;46:618\u201322.","journal-title":"Angew Chem Int Ed"},{"key":"432_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/B:PHAM.0000016234.73023.75","volume":"21","author":"X Tang","year":"2004","unstructured":"Tang X, Pikal M. Design of freeze-drying processes for pharmaceuticals: practical advice. J Pharm Res. 2004;21:191\u2013200.","journal-title":"J Pharm Res"},{"key":"432_CR19","unstructured":"Sperger D, Chen B, Offerdahl T, Hong S, Schieber L, Lubach J, Barich D, Munson E. Characterization of a new form of aspirin. AAPS J. 2006; 8:13961, www.aapsj.org\/abstracts\/AM_2006\/AAPS2006-002764.pdf ."},{"key":"432_CR20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1039\/C0CE00588F","volume":"13","author":"AD Bond","year":"2011","unstructured":"Bond AD, Solanko KA, Parsons S, Redder S, Boese R. Single crystals of aspirin form II: crystallization and stability. Cryst Eng Comm. 2011;13:399\u2013401.","journal-title":"Cryst Eng Comm"},{"key":"432_CR21","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/cg300404r","volume":"12","author":"PP Bag","year":"2012","unstructured":"Bag PP, Reddy CM. Evaporation method: a case study of aspirin, anthranilic acid and niflumic acid. Cryst Growth Des. 2012;12:2740\u20133.","journal-title":"Cryst Growth Des"},{"key":"432_CR22","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1021\/ie5046445","volume":"54","author":"D Jafari","year":"2015","unstructured":"Jafari D, Yarnezhad I, Nowee SM, Baghban SHN. Gas-antisolvent (GAS) crystallization of aspirin using supercritical carbon dioxide: experimental study and characterization. Ind Eng Chem Res. 2015;54:3685\u201396.","journal-title":"Ind Eng Chem Res"},{"key":"432_CR23","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1081\/DDC-100107243","volume":"27","author":"HA Garekani","year":"2001","unstructured":"Garekani HA, Sadeghi F, Badiee A, Mostafa SA, Rajabi-Siahboomi AR. Crystal habit modifications of ibuprofen and their physicomechanical characteristics. Drug Dev Ind Pharm. 2001;27:803\u20139.","journal-title":"Drug Dev Ind Pharm"},{"key":"432_CR24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/jps.20008","volume":"93","author":"R Panchagnula","year":"2004","unstructured":"Panchagnula R, Sundaramurthy P, Pillai O, Agrawal S, Raj YA. Solid-state characterization of mefenamic acid. J Pharm Sci. 2004;93:1019\u201329.","journal-title":"J Pharm Sci"},{"key":"432_CR25","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/cg0342314","volume":"4","author":"C Stoica","year":"2004","unstructured":"Stoica C, Verwer P, Meekes H, Van Hoof PJCM, FM K s, Vlieg E. Understanding the effect of a solvent on the crystal habit. Cryst Growth Des. 2004;4:765\u20138.","journal-title":"Cryst Growth Des"},{"key":"432_CR26","first-page":"822","volume-title":"Encyclopedia of pharmaceutical technology","author":"AK Tiwary","year":"2006","unstructured":"Tiwary AK. Crystal habit changes and dosage form performance. In: Swarbrick J, editor. Encyclopedia of pharmaceutical technology. 3rd ed. New York: Informa Healthcare; 2006. p. 822.","edition":"3"},{"key":"432_CR27","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1021\/mp200455u","volume":"8","author":"CE Marjo","year":"2011","unstructured":"Marjo CE, Bhadbhade M, Hook JM, Rich AM. Polymorphism and a metastable solvate of duloxetine hydrochloride. Mol Pharm. 2011;8:2454\u201364.","journal-title":"Mol Pharm"},{"key":"432_CR28","first-page":"289","volume":"22","author":"WFZ Ostwald","year":"1897","unstructured":"Ostwald WFZ. Physical chemistry. Stoechiom Verwandtschaftsl. 1897;22:289\u2013302.","journal-title":"Stoechiom Verwandtschaftsl"},{"key":"432_CR29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0731-7085(86)80086-3","volume":"4","author":"D Giron","year":"1986","unstructured":"Giron D. Applications of thermal analysis in the pharmaceutical industry. J Pharm Biomed Anal. 1986;4:755\u201370.","journal-title":"J Pharm Biomed Anal"},{"key":"432_CR30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2011.06.010","volume":"B1","author":"R Chadha","year":"2011","unstructured":"Chadha R, Gupta S, Shukla G. Crystal habit, characterization and pharmacological activity of various crystal forms of arteether. Acta Pharm Sinica. 2011;B1:129\u201335.","journal-title":"Acta Pharm Sinica"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-015-0432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-015-0432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-015-0432-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:33:25Z","timestamp":1559619205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-015-0432-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,16]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["432"],"URL":"https:\/\/doi.org\/10.1208\/s12249-015-0432-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,16]]}}}